Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol.
D000293:Adolescent; D000328:Adult; D002118:Calcium / Q000097:blood / Q000378:metabolism / Q000652:urine; D002762:Cholecalciferol / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004097:Dihydrotachysterol / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007011:Hypoparathyroidism / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000209:etiology; D008297:Male; D008875:Middle Aged; D013057:Spectrum Analysis; D013965:Thyroidectomy / Q000009:adverse effects; D014807:Vitamin D / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D014807:Vitamin D; D002762:Cholecalciferol; D004097:Dihydrotachysterol; D006909:Hydroxyproline; D002118:Calcium